To include your compound in the COVID-19 Resource Center, submit it here.

Lipegfilgrastim: Phase III data

A double-blind, European Phase III trial in 202 breast cancer patients showed that a single subcutaneous injection of 6

Read the full 193 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE